Acute Lymphoblastic Leukemia
What's New
Last Posted: Mar 26, 2024
- Prediction of tumor lysis syndrome in childhood acute lymphoblastic leukemia based on machine learning models: a retrospective study.
Yao Xiao et al. Front Oncol 2024 141337295 - Management of Down Syndrome-Associated Leukemias: A Review.
Anupam Verma et al. JAMA Oncol 2023 - Impact of TP53 gene variants on prognosis and survival of childhood acute lymphoblastic leukemia.
Sinem Firtina et al. Scandinavian journal of clinical and laboratory investigation 2023 1-7 - IL16 and factor V gene variations are associated with asparaginase-related thrombosis in childhood acute lymphoblastic leukemia patients.
Covida Mootoosamy et al. Pharmacogenomics 2023 - Design and Validation of a Custom Next-Generation Sequencing Panel in Pediatric Acute Lymphoblastic Leukemia.
José Vicente Gil et al. International journal of molecular sciences 2023 24(5) - Diagnostic utility of whole genome sequencing in adults with B-other acute lymphoblastic leukemia.
Daniel Leongamornlert et al. Blood advances 2023 - Pharmacotypes across the genomic landscape of pediatric acute lymphoblastic leukemia and impact on treatment response.
Lee Shawn H R et al. Nature medicine 2023 1 - Association of Inherited Genetic Factors With Drug-Induced Hepatic Damage Among Children With Acute Lymphoblastic Leukemia.
Yang Wenjian et al. JAMA network open 2022 12 (12) e2248803 - Deep learning-based transcriptome model predicts survival of T-cell acute lymphoblastic leukemia.
Zhang Lenghe et al. Frontiers in oncology 2022 121057153 - Genomics improves risk stratification of adults with T-cell acute lymphoblastic leukemia patients enrolled in measurable residual disease-oriented trials.
González-Gil Celia et al. Haematologica 2022 - The genomic landscape of pediatric acute lymphoblastic leukemia
SW Brady et al, Nature Genetics, September 1, 2022 - Realities of Pharmacogenomic and Minimizing Misconceptions and Medication Misadventures.
Duong Benjamin et al. Delaware journal of public health 2022 7(5) 12-15 - Integrated genomic analyses identify high-risk factors and actionable targets in T-cell acute lymphoblastic leukemia.
Zhu Haichuan et al. Blood science (Baltimore, Md.) 2022 4(1) 16-28 - SWOG 1318: A Phase II Trial of Blinatumomab Followed by POMP Maintenance in Older Patients With Newly Diagnosed Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia.
Advani Anjali S et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2022 JCO2101766 - Association of Genetic Ancestry With the Molecular Subtypes and Prognosis of Childhood Acute Lymphoblastic Leukemia.
Lee Shawn H R et al. JAMA oncology 2022 1 - Genetic Ancestry and Childhood Acute Lymphoblastic Leukemia Subtypes and Outcomes in the Genomic Era.
Rabin Karen R et al. JAMA oncology 2022 1 - Prognostic value of low-level MRD in adult acute lymphoblastic leukemia detected by low- and high-throughput methods.
Kotrova Michaela et al. Blood advances 2022 - NUDT15 genetic testing-guided 6-mercaptopurine dosing in children with ALL likely to be cost-saving in China.
Wei XiaoXia et al. International journal of hematology 2021 - A Machine Learning Approach to the Classification of Acute Leukemias and Distinction From Nonneoplastic Cytopenias Using Flow Cytometry Data.
Monaghan Sara A et al. American journal of clinical pathology 2021 - Association of Combined Focal 22q11.22 Deletion and IKZF1 Alterations With Outcomes in Childhood Acute Lymphoblastic Leukemia
DS Mangum et al, JAMA Oncology, August 19, 2021
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Page last updated:May 14, 2024
- Content source: